fMRI Study of Emotion Regulation in Patients Suffering From Obesity With or Without Binge Eating Disorder and Seeking Bariatric Surgery

NCT ID: NCT05131256

Last Updated: 2022-07-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-20

Study Completion Date

2025-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Obesity is a major public health problem and Binge eating disorder (BED) is very frequently observed in patients considered for weight loss surgery and seems to influence their outcome critically. Literature highlights a global emotional overload in individuals with BED, but few are known on the mechanisms involved. The purpose of this study is to fill this gap by comparing the neurofunctional profiles of emotion regulation between patients suffering from obesity, with or without BED and healthy participants during the performance of emotion regulation tasks. Results may help to understand the neural bases of the impairments observed in patients with obesity, with or without BED, which may in turn help to propose, in the long term, potential new therapeutic approaches.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Obesity is a major public health problem and frequently associated with Binge eating disorder (BED) in patients considered for weight loss surgery and seems to influence their outcome critically. It may be due, in part, to an ineffective or a maladaptive emotional regulation. Emotion regulation is the ability to exert control over one's own emotional state. The relative absence of this ability would indicate the presence of difficulties in emotion regulation, or an emotion dysregulation. Individuals with disordered eating may have a greater vulnerability to use maladaptive emotion regulation strategies. In the eating behaviours, an emotion dysregulation can cause weight gain that can lead to overweight or obesity. Accordingly, patients suffering from obesity, and with BED may have a greater vulnerability to use maladaptive emotion regulation strategies. However, few studies have investigated the neurofunctional profiles of emotion regulation in patients suffering from obesity with and without BED and seeking bariatric surgery.

The aim of the study is to explore the neural correlates of emotion regulation in patients suffering from obesity, with or without BED, in comparison with those of healthy participants. We also aim to describe the relationship between the neural correlates, eating behaviours and assessed psychological profiles.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Binge-Eating Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients suffering from obesity with BED

Group Type EXPERIMENTAL

Neurofunctional characterization of emotional regulation (fMRI)

Intervention Type BEHAVIORAL

Investigation of neurofunctional characterization of emotional regulation and its links with the eating behaviours of patients suffering from obesity using a comprehensive, clinical, and cognitive assessment and task-based MRI exams.

patients suffering from obesity without BED

Group Type ACTIVE_COMPARATOR

Neurofunctional characterization of emotional regulation (fMRI)

Intervention Type BEHAVIORAL

Investigation of neurofunctional characterization of emotional regulation and its links with the eating behaviours of patients suffering from obesity using a comprehensive, clinical, and cognitive assessment and task-based MRI exams.

healthy participants

Group Type ACTIVE_COMPARATOR

Neurofunctional characterization of emotional regulation (fMRI)

Intervention Type BEHAVIORAL

Investigation of neurofunctional characterization of emotional regulation and its links with the eating behaviours of patients suffering from obesity using a comprehensive, clinical, and cognitive assessment and task-based MRI exams.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neurofunctional characterization of emotional regulation (fMRI)

Investigation of neurofunctional characterization of emotional regulation and its links with the eating behaviours of patients suffering from obesity using a comprehensive, clinical, and cognitive assessment and task-based MRI exams.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients between 18 and 60 years old, men or women, right-handed
* Having a diagnosis of obesity class 2 or 3 and seeking bariatric surgery
* With Binge eating disorder (BED)
* Possibility to the use of MRI
* Patients being a native French speaker
* Patients enrolled in the national healthcare insurance program
* Patients consenting to participate to the study


* Patients between 18 and 60 years old, men or women, right-handed
* Having a diagnosis of obesity class 2 or 3 and seeking bariatric surgery
* Without Binge eating disorder (BED)
* Possibility to the use of MRI
* Patients being a native French speaker
* Patients enrolled in the national healthcare insurance program
* Patients consenting to participate to the study


* Men or women, right-handed, between 18 and 60 years old
* Without overweight nor obesity
* Native French speaker
* Individuals enrolled in the national healthcare insurance program
* Individuals consenting to participate to the study

Exclusion Criteria

* The presence of a current substance use disorder as defined by DSM-5 criteria
* The presence of neurological disorders or head trauma
* The presence of any intellectual disability, of pervasive developmental disorders or learning difficulties (especially of dysphasia and dyspraxia)
* A current mood episode as defined by DSM-5 criteria
* A diagnosis of schizophrenia or of bipolar disorder according to DSM-5 criteria
* Handling of psychotropics substances
* A sensorial impairment uncorrected (visual and/or hearing)
* Contraindication to the use of MRI
* Pregnant woman and people particularly protected by the law

Group 2: Patients suffering from obesity, seeking bariatric surgery, and without BED.


* The presence of a current substance use disorder as defined by DSM-5 criteria
* The presence of neurological disorders or head trauma
* The presence of any intellectual disability, of pervasive developmental disorders or learning difficulties (especially of dysphasia and dyspraxia)
* A current mood episode as defined by DSM-5 criteria
* A diagnosis of schizophrenia or of bipolar disorder according to DSM-5 criteria
* Handling of psychotropics substances
* A sensorial impairment uncorrected (visual and/or hearing)
* Contraindication to the use of MRI
* Pregnant woman and people particularly protected by the law

Group 3: Healthy participants.


* Past obesity
* The presence of neurological disorders or head trauma
* The presence of any intellectual disability, of pervasive developmental disorders or learning difficulties (especially of dysphasia and dyspraxia)
* Handling of psychotropics substances
* A sensorial impairment uncorrected (visual and/or hearing)
* Contraindication to the use of MRI
* Pregnant woman and people particularly protected by the law
* A current mood episode as defined by DSM-5 criteria
* A diagnosis of schizophrenia or of bipolar disorder according to DSM-5 criteria
* The presence of a current substance use disorder as defined by DSM-5 criteria
* A diagnosis of eating disorder as defined by DSM-5 criteria
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

CHU de Reims

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Damien JOLLY

Reims, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Farid BENZEROUK

Role: CONTACT

03 26 78 33 94 ext. 0033

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Farid BENZEROUK

Role: primary

03 26 78 33 94 ext. 0033

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PJ20148

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Brain Injury and Cognitive Function
NCT05922748 RECRUITING NA
Brain and Mindfulness
NCT03117478 COMPLETED NA